Form 4: Saba Capital Reduces Stake in BlackRock Health Sciences Term Trust Following Change of Control Transaction
SEC Form 4 Filing
Saba Capital Management, L.P. reports disposition of shares in BlackRock Health Sciences Term Trust (BMEZ) due to a change of control transaction.
Summary
- Saba Capital Management, L.P., a 10% owner and director of BlackRock Health Sciences Term Trust (BMEZ), filed a Form 4.
- The filing reports a disposition of 20,750,913 shares of common stock on April 21, 2025.
- The disposition occurred at a price of $14.21 per share.
- The transaction was executed pursuant to a tender of shares in a change of control transaction.
- Boaz Weinstein, also listed as a director and 10% owner, is associated with this filing.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reports a transaction without expressing positive or negative views.
Industry Context
Form 4 filings are standard disclosures required by the SEC when significant changes in ownership occur, providing transparency to the market regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 04/21/2025 | Date of transaction: Disposition of shares. |
| 04/22/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Saba Capital Management, BlackRock Health Sciences Term Trust, BMEZ, Disposition, Change of Control, Share Tender, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.